Search research articles
Contact Us
Filters
Showing results (181-190 of 234) with videos related to
Page
of 24
Sort By:
Journal of Hepatology
|
May 10, 2017
Effector CD8<sup>+</sup> T cell-derived interleukin-10 enhances acute liver immunopathology
Jessica Fioravanti, Pietro Di Lucia, Diletta Magini, et al.
Plos One
|
March 11, 2011
Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms
Martin Lagging, Galia Askarieh, Francesco Negro, et al.
Plos One
|
March 11, 2015
Changes in protein expression in two cholangiocarcinoma cell lines undergoing formation of multicellular tumor spheroids in vitro
Carlo Mischiati, Blendi Ura, Leda Roncoroni, et al.
BMC Gastroenterology
|
February 2, 2012
Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study
Geert Bezemer, Arthur R Van Gool, Elke Verheij-Hart, et al.
The Journal of Infectious Diseases
|
September 9, 2006
Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection
Ana I Romero, Martin Lagging, Johan Westin, et al.
Plos One
|
February 26, 2013
Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection
Jonas Söderholm, Jesper Waldenström, Galia Askarieh, et al.
Journal of Hepatology
|
May 24, 2016
Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B
Anna S Lok, Calvin Q Pan, Steven-Huy B Han, et al.
Gastroenterology
|
January 30, 2018
TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues
Carolina Boni, Andrea Vecchi, Marzia Rossi, et al.
Hepatology (Baltimore, Md.)
|
November 30, 2006
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection
Martin Lagging, Ana I Romero, Johan Westin, et al.
Journal of Hepatology
|
November 14, 2020
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B
Greta Acerbi, Ilaria Montali, Gennaro Domenico Ferrigno, et al.
Page
of 24
Search research articles
Search
Showing results (181-190 of 234) with videos related to
Sort By:
Page
of 24
Journal of Hepatology
|
May 10, 2017
Effector CD8<sup>+</sup> T cell-derived interleukin-10 enhances acute liver immunopathology
Jessica Fioravanti, Pietro Di Lucia, Diletta Magini, et al.
Plos One
|
March 11, 2011
Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms
Martin Lagging, Galia Askarieh, Francesco Negro, et al.
Plos One
|
March 11, 2015
Changes in protein expression in two cholangiocarcinoma cell lines undergoing formation of multicellular tumor spheroids in vitro
Carlo Mischiati, Blendi Ura, Leda Roncoroni, et al.
BMC Gastroenterology
|
February 2, 2012
Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study
Geert Bezemer, Arthur R Van Gool, Elke Verheij-Hart, et al.
The Journal of Infectious Diseases
|
September 9, 2006
Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection
Ana I Romero, Martin Lagging, Johan Westin, et al.
Plos One
|
February 26, 2013
Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection
Jonas Söderholm, Jesper Waldenström, Galia Askarieh, et al.
Journal of Hepatology
|
May 24, 2016
Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B
Anna S Lok, Calvin Q Pan, Steven-Huy B Han, et al.
Gastroenterology
|
January 30, 2018
TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues
Carolina Boni, Andrea Vecchi, Marzia Rossi, et al.
Hepatology (Baltimore, Md.)
|
November 30, 2006
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection
Martin Lagging, Ana I Romero, Johan Westin, et al.
Journal of Hepatology
|
November 14, 2020
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B
Greta Acerbi, Ilaria Montali, Gennaro Domenico Ferrigno, et al.
Page
of 24